Thus, dual targeting of ISG15 and HMGCR via our nanoplatform triggers a metabolic trap: while accumulated cholesterol transiently supports survival, the collapse of intermediate flux cripples CSC maintenance and tumor growth. Here, HMGCR is linked to neoplasm.